Colgate-Palmolive's Exposure to Emerging Markets Worries Investors

TheStreet.com Videos 0:54 mins

Colgate-Palmolive was in it to win it this December-ended quarter, with sales up 6.5% and earnings beating estimates by a penny. The toothpaste manufacturer managed to trump its larger competitor Procter and Gamble, which saw 3% sales growth over the period. Stock growth was more muted than expected as the company's exposure to emerging market volatility left some nervous. Colgate-Palmolive's sales outside the U.S. account for 80% of total revenue. TheStreet's Keris Lahiff has details from Wall Street.

View Comments (0)